# Cholecalciferol Supplementation in Hemodialysis Patients

> **NCT05922696** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 50 (actual)

## Conditions studied

- Anemia
- Hemodialysis Complication
- Vitamin D Deficiency

## Interventions

- **DRUG:** Cholecalciferol

## Key facts

- **NCT ID:** NCT05922696
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-15
- **Primary completion:** 2022-09-15
- **Final completion:** 2023-01-26
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05922696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05922696, "Cholecalciferol Supplementation in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05922696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*